SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
LeMaitre Vascular, Inc. (LMAT) trades at a trailing P/E of 43.5, forward P/E of 40.4. Trailing earnings yield is 2.30%, forward earnings yield 2.47%. PEG 1.42. Graham Number is $31.49.
Criteria proven by this page:
- VALUE (14/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 43.5); analyst consensus target implies downside from the current price ($101.50, 13.5%).
- Forward P/E 40.4 (down from trailing 43.5) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.42 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 2.30% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 2.47% as earnings recover.
- Analyst consensus target $101.50 (-13.5% downside) — slight downside risk — the market may be ahead of analyst expectations.
Overall SharesGrow Score: 73/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
14/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — LMAT
Valuation Multiples
P/E (TTM)43.5
Forward P/E40.4
PEG Ratio1.42
Forward PEG2.66
P/B Ratio6.38
P/S Ratio10.08
EV/EBITDA29.5
Per Share Data
EPS (TTM)$2.54
Forward EPS (Est.)$2.90
Book Value / Share$17.33
Revenue / Share$10.99
FCF / Share$3.28
Yields & Fair Value
Earnings Yield2.30%
Forward Earnings Yield2.47%
Dividend Yield0.77%
Graham Number$31.49
SharesGrow IV$103.28 (-12%)
Analyst Target$101.50 (-13.5%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
44.2 |
1.50 |
5.35 |
5.25 |
0.71% |
| 2017 |
35.1 |
0.59 |
5.50 |
5.99 |
0.69% |
| 2018 |
20.0 |
0.67 |
3.53 |
4.35 |
1.19% |
| 2019 |
39.7 |
-1.74 |
4.81 |
6.08 |
0.95% |
| 2020 |
38.6 |
2.51 |
4.75 |
6.34 |
0.94% |
| 2021 |
39.5 |
1.89 |
4.18 |
6.88 |
0.88% |
| 2022 |
49.0 |
-1.89 |
3.77 |
6.26 |
1.09% |
| 2023 |
41.9 |
0.94 |
4.23 |
6.52 |
0.99% |
| 2024 |
47.0 |
1.06 |
6.13 |
9.41 |
0.70% |
| 2025 |
31.8 |
1.06 |
4.67 |
7.36 |
0.99% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.55 |
$89.15M |
$10.59M |
11.9% |
| 2017 |
$0.86 |
$100.87M |
$17.18M |
17% |
| 2018 |
$1.13 |
$105.57M |
$22.94M |
21.7% |
| 2019 |
$0.88 |
$117.23M |
$17.93M |
15.3% |
| 2020 |
$1.04 |
$129.37M |
$21.22M |
16.4% |
| 2021 |
$1.25 |
$154.42M |
$26.91M |
17.4% |
| 2022 |
$0.93 |
$161.65M |
$20.64M |
12.8% |
| 2023 |
$1.34 |
$193.48M |
$30.11M |
15.6% |
| 2024 |
$1.93 |
$219.86M |
$44.04M |
20% |
| 2025 |
$2.52 |
$249.6M |
$57.73M |
23.1% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$2.89 |
$2.64 – $2.98 |
$278.99M |
$278.7M – $279.33M |
7 |
| 2027 |
$3.15 |
$2.93 – $3.28 |
$303.01M |
$294.71M – $308.11M |
7 |
| 2028 |
$3.35 |
$3.34 – $3.35 |
$329.11M |
$328.28M – $329.95M |
3 |
| 2029 |
$0.00 |
$0.00 – $0.00 |
$350.44M |
$342.68M – $356.84M |
1 |
